The Europe Home Care Market was valued at USD 123.4 Billion in 2024, and is projected to reach USD 192.86 Billion by 2030, rising at a CAGR of 7.70%. The Europe home care market is experiencing substantial growth driven by a confluence of demographic, economic, and technological factors. A key driver is the increasing geriatric population, contributing to a higher incidence of chronic diseases. The European Commission's 2024 Ageing Report projected a rise in public spending on healthcare and long-term care to 25.6% of the EU's GDP by 2070, underscoring the escalating demand for care services.
Technological advancements in medical devices have significantly propelled market expansion, alongside the rising prevalence of chronic conditions and the cost-effectiveness of home care solutions. This has increased the acceptance of home care as a preferable alternative to institutional settings. The availability of user-friendly portable devices, such as heart rate and glucose monitors, has enhanced the efficiency of managing lifestyle diseases at home. The growing prevalence of respiratory illnesses, including asthma, COPD, and sleep apnea, fueled by air pollution and lifestyle choices, is also a major catalyst for the respiratory care devices market within the home care sector.
The EU4Health Programme is a significant example of initiatives strengthening European health systems by promoting the digital transformation of healthcare, which is crucial for expanding remote care solutions and improving accessibility. Complementing this, the stringent European regulatory environment ensures the safety and efficacy of medical devices used in home care throughout their lifecycle. These interconnected factors collectively contribute to the robust growth of the Europe home care market.
This product will be delivered within 1-3 business days.
Technological advancements in medical devices have significantly propelled market expansion, alongside the rising prevalence of chronic conditions and the cost-effectiveness of home care solutions. This has increased the acceptance of home care as a preferable alternative to institutional settings. The availability of user-friendly portable devices, such as heart rate and glucose monitors, has enhanced the efficiency of managing lifestyle diseases at home. The growing prevalence of respiratory illnesses, including asthma, COPD, and sleep apnea, fueled by air pollution and lifestyle choices, is also a major catalyst for the respiratory care devices market within the home care sector.
The EU4Health Programme is a significant example of initiatives strengthening European health systems by promoting the digital transformation of healthcare, which is crucial for expanding remote care solutions and improving accessibility. Complementing this, the stringent European regulatory environment ensures the safety and efficacy of medical devices used in home care throughout their lifecycle. These interconnected factors collectively contribute to the robust growth of the Europe home care market.
Europe Home Care Market Report Highlights
- The service segment held the largest market share of over 80.0% in 2024
- Home care equipment is anticipated to witness the fastest growth over the forecast period, driven by the shift to home-based care, technological advancements, and cost-saving incentives
- Cancer care held the largest share in the indication segment due to Europe's aging population and rising cancer cases, projected to increase by 31% and 35% by 2025, respectively
- The growth of the European home care market is driven by an aging population, a rising demand for personalized in-home services, and innovations in telehealth and medical technologies
- Germany dominated the Europe home care market in 2024 owing to factors such as chronic disease prevalance, technological advancements, and government support
- In August 2024, Medtronic received FDA approval for Simplera, a more compact and disposable version of its continuous glucose monitor, and entered into a global partnership with Abbott to expand CGM options for people living with diabetes
Why Should You Buy This Report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Europe Home Care Market Variables, Trends & Scope
Chapter 4. Europe Home Care Market: Component Estimates & Trend Analysis
Chapter 5. Europe Home Care Market: Indication Estimates & Trend Analysis
Chapter 6. Europe Home Care Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The companies profiled in this Europe Home Care market report include:- Siemens Healthineers AG
- Medtronic
- Health Care At Home Private Limited
- BAYADA Home Health Care
- Inizio
- Accredo Health Group, Inc.
- Mears Group PLC
- OMRON Corporation
- Johnson & Johnson Medical Limited
- DomusVi Group
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 100 |
Published | April 2025 |
Forecast Period | 2024 - 2030 |
Estimated Market Value ( USD | $ 123.4 Billion |
Forecasted Market Value ( USD | $ 192.86 Billion |
Compound Annual Growth Rate | 7.7% |
Regions Covered | Europe |
No. of Companies Mentioned | 11 |